A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis

World Journal of Gastroenterology

Volumn 14, Issue 1, 2008, Pages 114-119

  Liang, Hong Liang ^a   Ouyang, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Peroxisome proliferators activated receptor ; Rosiglitazone; Ulcerative colitis

Indexed keywords

MESALAZINE; ROSIGLITAZONE;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EDEMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAUNDICE; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REMISSION; ULCERATIVE COLITIS;

EID: 39849093143     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.114     Document Type: Article

References (30)